Additional Slides - DA. Universal Screening Severe NHB (≥ X* mg/dL) No NHB Clinical Assessment/ Current Practice Severe NHB (≥ X* mg/dL) No NHB US Newborn.

Slides:



Advertisements
Similar presentations
Considerations for the Neonate Delivered at Home Susan J Dulkerian, MD Director of Nurseries, Mercy Medical Center Fetus and Newborn Subcommitee Chair.
Advertisements

Slide 1Fig. 2.1a, p.25. Slide 2Fig. 2.1b, p.25 Slide 3Table 2.1, p.25.
OVERVIEW OF AMINO ACID METABOLISM ENVIRONMENT ORGANISM Ingested protein Bio- synthesis Protein AMINO ACIDS Nitrogen Carbon skeletons Urea Degradation (required)
Slide 1Fig. 22.1, p.669. Slide 2Fig. 22.3, p.670.
Slide 1Fig. 17.1, p.513. Slide 2Table 17.1, p.514.
Slide 1Fig. 11.1, p.337. Slide 2Fig. 11.2, p.338.
Slide 1Fig. 19.1, p Slide 2Fig. 19.2, p. 583.
Slide 1Fig. 21.1, p.641. Slide 2Fig. 21.2, p.642.
Slide 1Fig. 10.1, p.293. Slide 2Fig. 10.1a, p.293.
Hyperbilirubinemia: Discussion Alexis Thompson, MD Catherine Wicklund, MS, CGC.
Slide 1Fig. 5.1, p.113. Slide 2Fig. 5.1a, p.113 Slide 3Fig. 5.1b, p.113.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Total Serum Bilirubin Levels at or Above the ETT Wu YW, Kuzniewicz MW, Wickremasinghe.
1 times table 2 times table 3 times table 4 times table 5 times table
275 BCH Miss Tahani Al-Shehri
Universal Predischarge Screening for Neonatal Hyperbilirubinemia Report from Evidence Review Secretary's Advisory Committee on Heritable Disorders in Newborns.
Neonatal Jaundice Hyperbilirubinemia Fred Hill, MA, RRT.
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
Dr.Abdulaziz Alsoumali Intern Alyamamh hospital Pediatric rotation
Project/Product Title PI (and Co-PI) Affiliation August 10, 2012.
Neonatal Hereditary Spherocytosis Prof. Rai Muhammad Asghar Head of Paediatric Department RMC & Allied Hospitals.
Switch to ATV/r-containing regimen  ATAZIP. Mallolas J, JAIDS 2009;51:29-36 ATAZIP ATAZIP Study: Switch LPV/r to ATV/r  Design  Endpoints –Primary:
Table 1. Cluster 1 Patients Attaining Treatment Levels % Patients Attaining Treatment Levels 24 Weeks64 Weeks E/S + N † E/S † N†N† E/S + N † E/S † Cluster.
Evidence Review Group: Past to Present James M. Perrin, MD Professor of Pediatrics, Harvard Medical School MGH Center for Child and Adolescent Health Policy.
Therapeutic Plasma Exchange for hyperbilirubinemia in two newborns during Extra Corporeal Membrane Oxygenation Linda Koster-Kamphuis, pediatric nephrologist.
Neonatal Bilirubin Levels and Developmental Outcome Dennis Odell Rachel Duchoslav Erin Clark Rena Vanzo Lisa Samson-Fang.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
$100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300 $400 $500 $100 $200 $300.
Role of c-3279T>G mutation in the UGT1A1 promoter in the development of neonatal unexplained indirect hyperbilirubinemia Tomerak RH, Helal NF, Shaker OG,
Tables Learning Support
On the screens click on the number you think is the right answer. Three times tables Good luck!
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Effect of Laboratory Calibration of Neonatal Bilirubin Kuzniewicz MW, Greene DN,
Implementation of a Flowsheet to Better Manage Bilirubin Levels in Newborns Dr. Alia Chauhan, MD, FAAP Assistant Professor of Pediatrics & Family Medicine.
Characteristics of amplitude-integrated electroencephalography in neonates with excessive hyperbilirubinemia Division of Neonatology, the Children's Hospital.
10/3/2014. Εμφραγμα - Στηθαγχη - Πονος στο στηθος : Εμφραγμα μυοκαρδιου λεμε την βαρυτατη εκεινη κατασταση που οφειλεται στην αποφραξη που μπορει να γινει.
Universal Predischarge Screening for Neonatal Hyperbilirubinemia Report from Evidence Review Secretary's Advisory Committee on Heritable Disorders in.
Copyright © 2017 American Academy of Pediatrics.
Hyperbilirubinemia Web Conference April 26,
Neonatal Hemolytic Jaundice
Chapter 36 Hemolytic Disorders.
Copyright © 2017 American Academy of Pediatrics.
Copyright © 2017 American Academy of Pediatrics.
Copyright © 2017 American Academy of Pediatrics.
Phototherapy Plasmapheresis
Heme.
continued on next slide
Volume 12, Issue 1, Pages (January 1983)
High Risk neonatal nursing
Cord Blood IL-16 Is Associated with 3-Year Neurodevelopmental Outcomes in Perinatal Asphyxia and Hypoxic-Ischaemic Encephalopathy Dev Neurosci 2017;39:59-65.
Times Tables.
Presentation Test. Second Slide Third Slide It worked.
                                                                                                                                                                                                                                                
continued on next slide
continued on next slide
شاخصهای عملکردی بیمارستان
The Newborn Hearing Screening Programs At Inova Hospitals
مدل زنجیره ای در برنامه های سلامت
مبانی غربالگری بیماریها
فرق بین خوب وعالی فقط اندکی تلاش بیشتر است
David K. Stevenson, MD  Clinics in Perinatology 
Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W.
Example of an algorithm recommending timing for follow-up of newborns based on their predischarge bilirubin levels, gestation, and related risk factors.
Epilepsy12 Patient Record Summary Dashboard
3 times tables.
6 times tables.
continued on next slide
HRs for prostate cancer by medication status.
A Child with Jaundice M Rawashdeh, MD, MSc, FRCP, FRCPCH
Risk designation of term and near-term well newborns based on hour-specific serum bilirubin values; used to interpret discharge bilirubin levels to predict.
continued on next slide
Nomogram for designation of risk in 2840 well newborns at 36 or more weeks’ gestational age with birth weight of 2000 g or more or 35 or more weeks’ gestational.
Presentation transcript:

Additional Slides - DA

Universal Screening Severe NHB (≥ X* mg/dL) No NHB Clinical Assessment/ Current Practice Severe NHB (≥ X* mg/dL) No NHB US Newborn Cohort CBE No CBE CBE No CBE Model Schematic *X = bilirubin level of 25 mg/dL or 30 mg/dL NHB = neonatal hyperbilirubinemia

Table 5. Projected Cases of CBE Averted US Newborn Cohort Incidence of CBE per 100,000 Projected Cases of CBE Impact of Screening* Projected Cases of CBE Averted 4,000, ,000, ,000, ,000, CBE = Chronic bilirubin encephalopathy *Proportion of cases averted